Citi downgrades Calliditas to neutral, cites takeover offer (NASDAQ:CALT)


Chessboard with chess pieces and wooden blocks with the word mergers and acquisitions


Citi has downgraded Calliditas Therapeutics (NASDAQ:CALT) to neutral and raised its price target, citing the recent takeover offer by Asahi Kasei.

The investment bank said it doesn’t expect any other bidders to emerge for the company, given that the board has

Source link

Leave A Reply

Your email address will not be published.